Survival prognostic factors and clinical outcomes in patients with spinal metastases.
OBJECTIVE
In patients with metastatic disease to the spine, patient selection for surgery and the extent of surgery to perform thereafter remains controversial, with the patient's survival prognosis the most important consideration. For this reason, we conducted a prospective study investigating prognostic factors and clinical outcomes in a consecutive series of patients with vertebral metastases.


METHODS
A total of 142 consecutive patients with vertebral metastases referred to us for consideration of surgery were prospectively enrolled into this study. Of these, 118 patients subsequently underwent palliative surgery for intractable pain or radiculopathy, bony instability or spinal cord compression. Patients were followed up for 12 months or until death. A multivariate analysis of the patients was conducted using the Cox proportional hazards model. The survival predictive accuracy of the Tokuhashi score was also investigated. For the patients who underwent surgery, pre- and post-operative outcomes were assessed on pain, neurological deficit, function and overall quality of life.


RESULTS
The overall 12-month mortality rate was 50.7% and the median survival was 5 months. Multivariate analysis showed that independent prognostic factors for survival after spinal metastases include primary tumour type, Karnofsky functional status, ASA score and pain. Neither the original nor revised Tokuhashi scores were reliable in predicting survival in our European population. In the patients who underwent operative intervention, there was an immediate and prolonged improvement in pain, neurological deficit, function and quality of life in the majority of cases.


CONCLUSIONS
The potential for rapid and maintained improvement in clinical outcome and quality of life should be considered when selecting patients with metastatic disease to the spine for surgery rather than basing decisions solely on survival prognostic factors comprising current scoring systems.
Pointillart
Vincent
V
Spinal Surgery Unit, Department of Orthopaedics, University Hospital of Bordeaux, Place Amélie Raba Léon, 33076, Bordeaux, France.
Vital
Jean-Marc
JM
Salmi
Rachid
R
Diallo
Abou
A
Quan
Gerald M
GM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D011446:Prospective Studies; D013125:Spinal Neoplasms / Q000401:mortality* / Q000556:secondary* / Q000601:surgery
Spine (Phila Pa 1976). 1990 Nov;15(11):1110-3
1702559
Spine (Phila Pa 1976). 1996 Sep 15;21(18):2143-8
8893440
Acta Orthop Scand. 1995 Apr;66(2):143-6
7740944
Eur J Surg Oncol. 2007 Sep;33(7):914-9
17210240
Spine (Phila Pa 1976). 2005 Oct 1;30(19):2186-91
16205345
Spine (Phila Pa 1976). 1999 Nov 1;24(21):2240-6
10562991
Eur Spine J. 2008 Nov;17(11):1488-95
18787846
Spine (Phila Pa 1976). 2005 Oct 1;30(19):2222-6
16205351
Cancer. 2005 Jan 15;103(2):320-8
15593360
Spine (Phila Pa 1976). 2001 Feb 1;26(3):298-306
11224867
Spine (Phila Pa 1976). 2009 Jan 1;34(1):69-73
19127163
Clin Orthop Relat Res. 2005 Jul;(436):196-201
15995441
J Bone Joint Surg Br. 2005 May;87(5):698-703
15855375
Eur Spine J. 2006 Feb;15(2):196-202
15744540
J Neurosurg Spine. 2008 Mar;8(3):271-8
18312079
Cancer. 2007 Nov 1;110(9):2042-9
17853394
Lancet. 2005 Aug 20-26;366(9486):643-8
16112300
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):280-7
18676092
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
8433390
Spine (Phila Pa 1976). 2006 Nov 15;31(24):2849-56
17108840
Spine (Phila Pa 1976). 1997 Oct 1;22(19):2293-8
9346151
Ann Surg Oncol. 2007 Feb;14(2):998-1004
17083006
Cancer. 1995 Oct 15;76(8):1453-9
8620423